Myrosinase Bioactivated Gglucoraphanin for the Treatment of Neurodegenerative Diseases (GRA-MYR-ND)
Abroad (travel likely)Recruiting
Conditions
PARKINSON DISEASE (Disorder) · Multiple Sclerosis (MS) - Relapsing-remitting · Pediatric Patients Affected by Neuromuscolar and Degenerative Diseases
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
IRCCS Centro Neurolesi Bonino Pulejo, Messina, Italy
Study leads
Emanuela Mazzon
Principal Investigator
IRCCS Centro Neurolesi Bonino Pulejo